P
arkinson disease (PD) is a movement disorder in which the dopamine-producing cells of the basal ganglia progressively degenerate. 1 Basal ganglia degeneration results in many motor and nonmotor symptoms in individuals with PD due to vast global connections in the brain between the basal ganglia and cortical areas. [2] [3] [4] [5] [6] [7] For example, individuals with PD eventually lose the ability to complete well-learned movements automatically, 8, 9 as the basal ganglia are believed to help automate control of these movements. 10 -12 Automatic movements are defined as the performance of a skill with little or no demand on attention, 13 also referred to as automaticity. As the automatic movement control system does not function properly in individuals with PD, they are forced to compensate for impaired automaticity by consciously controlling movements that were once automatic. Consciously controlling all movements requires increased attentional demand, 14 -17 resulting in a greater chance of falling and injury if attention needs to be shared or is diverted away from control of the movement. However, there is evidence to suggest that when a particular instruction is given, aimed at directing one's attention to a specific location (such as toward the manipulation of an object as opposed to the movement of their limbs), individuals with PD are able to efficiently use automatic processes to control the movement, and it provides benefits to movement performance. 18, 19 This instruction pertains to where attention is focused when performing movement tasks.
It has been well supported that the location on which a person focuses attention while performing novel tasks has a critical influence on control of movement. 20, 21 For instance, people can focus on the control of an object that is being manipulated (such as focusing on the motion of the head of a golf club during a golf putt, 22 the rungs of vertical jump equipment during a vertical leap, 23 or stabilizing a balance platform during a postural task 24, 25 ), or they can focus on their limbs to ensure that the movement is accurate (such as focusing on locking wrist and elbow joints during the swinging motion of the arms in a golf putt, 22 full arm swing and the tips of the individual's finger during a vertical jump, 23 or minimizing movement of one's feet during a postural task 24, 25 ). Several studies have shown that when healthy individuals perform a novel task and focus their attention on an object while it is being controlled (ie, an external focus of attention [EFA] ), performance is typically more successful than when the focus of attention is directed toward controlling movement of one's limbs (ie, an internal focus of attention [IFA] ) or when no instruction is provided. 23, 24, 26, 27 It has been argued that adopting an EFA allows use of automatic processes (that are believed to be controlled by sensorimotor cortical areas typical of automatic movement control 28 ) and, therefore, requires less conscious control of the movement with optimal performance. 25 On the other hand, an IFA is argued to involve greater recruitment of frontal areas (such as the prefrontal cortex, premotor cortex, and anterior cingulate cortex) and less recruitment of sensorimotor regions, 28 causing detriments to performance. 25 Therefore, as automatic processes are utilized when focus of attention is directed externally on the manipulation of objects and individuals with PD demonstrate impairments in using their automatic systems, it might be expected that an EFA would induce greater movement impairment and prove detrimental to performance in individuals with PD.
Interestingly, when asked to control postural stability while standing on an inflated disk (increased task difficulty) placed on top of a forceplate, individuals with PD demonstrated significantly less postural sway (improved control) when instructed to focus attention on minimizing movements of the disk (EFA) in comparison with minimizing movements of their feet (IFA) or when only instructed to stand still. 18 It is important to note that during testing, individuals with PD continued their normal dopamine replacement regimen, also referred to as "on" medications. These findings suggest that when individuals with PD are on dopamine replacement, they are able to effectively use automatic processes that prove beneficial for movement control. However, if an EFA promotes involvement of neural circuits recruited during automatic control of movement, which are dysfunctional in individuals with PD, removing dopamine that is vital for basal ganglia functioning ("off" medication state) might be expected to interfere with the benefits of focusing attention externally while controlling posture. In other words, when dopamine is depleted, an EFA might be expected to result in greater center-of-pressure displacement and variability (worse postural control) compared with an IFA.
Although pinnacle research has explored the influence of dopaminergic therapy on postural control in participants with PD, 29 -34 an investigation of the influence of focus of attention (external versus internal versus control) on postural stability in individuals with PD that includes withdrawal and presence of dopamine replacement medication (greater versus lesser function of automatic processes) has yet to be completed. This examination would provide important insights into the influence of the basal ganglia on attentional focus (ie, external versus internal), automatic movement control, and pathology in people with PD.
Therefore, the first aim of the current study was to determine whether an EFA or an IFA is beneficial for control of postural stability in participants with PD when dopamine replacement was not present. It was expected that if the basal ganglia are critical for automatic processes involved in movement control when an EFA is adopted, relative depletion of dopamine (off medications) might influence more postural sway (ie, greater postural displacement and variability) when participants with PD focus attention externally on minimizing movements of a platform (automatic control relying on the basal ganglia) compared with focusing internally on minimizing movements of their feet (frontal areas with less basal ganglia involvement).
The second aim of this study was to investigate the interaction among the location in which participants with PD focus attention, medication state (on versus off dopamine medications), and postural stability. If the basal ganglia are
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involved in the automatic processes recruited when an EFA is adopted, it was expected that the greatest amount of postural sway would be found when participants with PD were off dopamine medications and focusing externally on minimizing the movements of a platform, which would maximize impaired basal ganglia involvement. In contrast, if participants with PD are able to efficiently use their automatic processes when dopamine is present (on medications), the least amount of postural sway was expected to be found when participants with PD were on dopamine medications and focusing externally. 18,19 It was not expected that postural stability would differ between medication states in participants with PD when an IFA was adopted, as the basal ganglia were expected to be less involved during movements mediated by frontal areas compared with automatic control of movement and thus not as influenced by changes in dopamine levels.
Method Participants
Nineteen individuals diagnosed with idiopathic PD by a neurologist participated in this study. Participants were recruited from the patient database at the Movement Disorders Research and Rehabilitation Centre (MDRC) at Wilfrid Laurier University in Waterloo, Canada. Recruitment took place from May 2015 to February 2016. Participants (both male and female) were included if they were diagnosed with idiopathic PD by a neurologist, could understand verbal English instructions, had the ability to walk 10 m without assistance, and could stand for 5 minutes without assistance. Exclusion criteria included having a neurological disease other than PD; having PD but not being prescribed dopaminergic medication (de novo); experiencing light-headedness or dizziness; the presence of dyskinesia, peripheral neuropathy, diabetes, or orthopedic disorders; and being clinically diagnosed with dementia-all aspects that might negatively affect postural control. Prospective participants (chosen at random from the MDRC patient database in which participants had previously provided contact information and permission to be contacted for research studies) were recruited by telephone, during which inquiry regarding inclusion and exclusion criteria took place. Participants were informed of the experimental protocols and requirements of this study. Prior to testing, written consent was obtained according to the Declaration of Helsinki.
Experimental Setup
Participants' postural control was measured utilizing the Biodex Balance System SD (Biodex Medical Systems Inc, Shirley, New York), which has been found to reliably assess postural stability [35] [36] [37] and has previously been used to evaluate postural control in individuals with PD. 38, 39 The Biodex system objectively measures postural control with a computerized platform and provides a postural stability index (PSI; angular excursion of the center of gravity) as an average (displacement) and standard deviation (variability) of the overall, anterior-posterior, and medial-lateral degrees of the center-of-pressure movement, which were the main outcome measures. These parameters were calculated by the Biodex Balance System SD utilizing displacement (in degrees), relative to level, in all directions. For these dependent variables, higher assessment scores (greater center-of-pressure displacement and variability) reflect worse postural control. As previous work has shown that the difficulty of the task is important to parse out differences in postural control when comparing different focus-of-attention tasks, 19 the dynamic platform control setting on the Biodex Balance System SD was utilized for this experiment.
The Biodex system possesses 12 platform stability settings in which setting 12 is a stable platform (lowest degree of difficulty) and setting 1 is an unstable platform (greatest degree of difficulty). Settings 2 through 11 provide a challenge to stability between these 2 extremes. The platform stability setting utilized for each participant was determined by the postural control capability of each individual. This capability was evaluated prior to testing on the first day of data collection in which participants stood on the Biodex platform with the postural stability setting at 7 (middle level of difficulty) and asked to control their postural stability while the platform became unstable. During this "evaluation procedure," if after 10 seconds of controlling one's posture the overall PSI was 6.0 or greater (a displaced center of pressure that indicated lost postural control), a less challenging stability setting (greater than 7) was evaluated. Once an overall PSI of 6.0 was not exceeded, this marked the platform stability setting utilized throughout data collection. If participants' overall PSI did not exceed 6.0 on platform stability setting 7, a more challenging setting (less than 7) was used to evaluate postural control. The stability setting difficulty was gradually increased until the participants' overall PSI exceeded 6.0. Once this took place, the platform stability setting attempted in the prior evaluation (one setting less difficult) was chosen as the difficulty setting used for the protocol. Once the evaluation procedure was completed, the determined platform stability setting (platform difficulty) was utilized for both on and off medication state protocol testing.
Therefore, each participant completed testing on a personalized platform stability setting that posed an optimal challenge to postural control, and this difficulty was the same when in the on or off medication state. Due to the challenge of the protocol, participants wore a harness throughout the experimental setup and protocol. The harness did not support the participant in the event that a large amount of sway took place, but was rather a precaution in the event that a fall was to take place.
All participants completed the postural stability protocol in both an on (approximately 1 hour after taking their normal dopaminergic medication) and off (after at least 12 hours of withdrawal from their normal dopaminergic medication) dopamine replacement medication state. Data collection in the on and off states was completed on different days and counterbalanced (10 participants completed the protocol in the on state first, and 9 participants completed the protocol in the off state first), with at least 48 hours separating these 2 occasions. Prior to completing the experimental protocol, patient symptom severity was
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February 2017 Volume 97 Number 2 Physical Therapy  211 assessed with the Unified Parkinson's Disease Rating Scale Motor Section (UPDRS-III) by a movement disorders specialist, who was certified in UPDRS assessment (for several clinical trials) and, during his training, followed alongside a movement disorders-trained neurologist within a movement disorders clinic, similar to a neurology resident, for 4 years.
Protocol
After the platform setting difficulty was determined, participants were asked to stand still and look straight ahead for 30 seconds while completing 3 attention conditions that followed the protocol completed by Wulf et al 18 : (1) EFA, in which participants were asked to "focus on minimizing the movements of the platform"; (2) IFA, where participants were asked to "focus on minimizing the movements of their feet"; and (3) control, in which participants were asked to "stand still." Three trials were performed for each condition, with data collection taking place in a randomized order. The data collection protocol in participants' on and off medication states was completed identically. As there is an element of cognitive demand associated with the present protocol, general cognitive status was assessed while participants were on dopamine medications utilizing the Montreal Cognitive Assessment (MoCA). This assessment took place on either the participants' first or second visit for data collection, depending on which day the on dopaminergic medications testing took place. Last, although the level of challenge was set relative to each participant's capability, if a fall were to take place within the harness, the trial was discontinued and redone. The number of falls within the harness was not collected.
Data Analysis
To determine whether dopaminergic medications improved motor function of participants included in the present study, a dependent-samples t test was utilized to find differences in UPDRS-III scores between medication states (on versus off). To investigate whether an EFA or an IFA is more beneficial for postural stability control in participants with PD while off dopamine replacement, a 2-factor, mixed, repeated-measures analysis of variance (condition ϫ trial) was used. In order to investigate the interaction between the location in which participants with PD focus attention, medication state, and postural stability, a 3-factor, mixed, repeated-measures analysis of variance (medication state ϫ condition ϫ trial) was utilized. To determine where significant differences were with respect to main effects and interactions, a Tukey honestly significant difference post hoc analysis was used. The level of significant difference was set at PϽ.05. Results were analyzed using StatSoft STATISTICA 8.0.550 (StatSoft Inc, Tulsa, Oklahoma).
Role of the Funding Source
This study was supported, in part, by the Canada Foundation for Innovation to Dr Almeida (grant number: 20774).
Results
Participants (17 male, 2 female) were an average age of 71.4 years (SDϭ6.1, rangeϭ60 -81), had been diagnosed with PD for a mean of 7.6 years (SDϭ5.9, rangeϭ0. Graphic illustration of (A) average anterior-posterior postural stability index and (B) anteriorposterior postural stability index standard deviations while participants completed the protocol in both the on (black columns) and off (gray columns) dopamine medication states. External focus of attention (EFA) signifies the condition in which participants were asked to "focus on minimizing the movements of the platform," internal focus of attention (IFA) signifies the condition in which participants were asked to "focus on minimizing the movements of their feet," and Control signifies the condition in which participants were asked to "stand still." * Significant difference at the PϽ.05 level. 
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Discussion
This was the first study, to our knowledge, to explore the interaction between dopaminergic replacement medication and focus of attention on postural stability in PD. Previous work has shown that when participants with PD continued their normal dopamine replacement regimen, they demonstrated significantly less postural sway (improved control) when instructed to focus attention on minimizing movements of the platform (EFA) in comparison with minimizing movements of their feet (IFA) or simply standing still. 18 This finding suggests that when dopamine replacement restores functioning of the degenerated dopaminergic neurons, individuals with PD are able to recruit and utilize automatic processes in a relatively effective manner, despite the pathological degeneration of automatic pathways. Therefore, it was expected that if the basal ganglia are critical for automatic processes involved in movement control (when an EFA is adopted), depleting dopamine (exacerbated effect of basal ganglia damage while participants are off medications) might influence greater postural sway displacement and variability (ie, worse postural control) when participants with PD focus attention externally (automatic control relying on the basal ganglia) compared with focusing attention internally (frontal areas with less basal ganglia involvement).
Thus, the first aim of the current study was to determine whether an EFA or an IFA is more beneficial for control of postural stability in participants with PD when dopamine replacement was not present. Results revealed that while off dopamine replacement, participants with PD demonstrated significantly lower center-of-pressure sway displacement and variability in the anteriorposterior direction while focusing internally on minimizing the movements of their feet compared with the control condition. More importantly, participants' anterior-posterior sway while focusing externally on minimizing the movement of the platform was significantly more variable compared with focusing internally. Therefore, in contrast to findings that demonstrate optimal control of postural stability in participants with PD while focusing externally with the presence of dopamine, 18,19 the present findings show that when dopamine is depleted, the greatest control of postural stability was found when an IFA was adopted compared with an EFA. These findings might have 2 key implications.
First, since participants with PD demonstrated worse postural control when focusing attention externally compared with focusing internally, an EFA may have recruited automatic processes involving a degenerated basal ganglia that lacked optimal function without dopamine replacement, thereby exacerbating dysfunction. Thus, induced use of the damaged motor output from the basal ganglia (through attentional instruction to focus externally) may have been the mechanism underlying the worse postural control while focusing externally. These findings also suggest that when participants with PD focused externally in the previous study conducted by Wulf et al, 18 an EFA involved recruitment of relatively functional basal ganglia due to the presence of dopamine, which allowed optimal performance through involvement of automatic processes.
Second, as participants with PD demonstrated optimal postural control while focusing attention internally, this instruction may have promoted recruitment of frontal areas for control of movement that either bypassed the damaged basal ganglia, or were less influenced by basal ganglia degeneration, allowing for greater control. If these are the 2 mechanisms underlying an EFA and IFA while controlling postural stability, it might be expected that postural stability would only differ between dopamine replacement medication states (on versus off) while individuals with PD focus attention externally (due to suggested involvement of the basal ganglia), but not internally (due to the suggested lack of basal ganglia involvement).
The second aim of this study was to investigate the interaction among the location in which participants with PD focus attention, medication state, and postural stability. If the basal ganglia were involved in the automatic processes recruited when an EFA was adopted, it might be expected that the greatest amount of postural sway would be found when participants with PD were off dopamine medications and focusing externally on minimizing the movements of a platform, as this condition would maximize impaired basal ganglia involvement. However, the results of this study demonstrate that this was not the case. Although no significant difference in postural stability was found during the EFA condition in the on medication state compared with the off medication state, anterior-posterior sway variability while focusing attention externally on medications was greater than that while focusing attention externally while off medications (Figure) . It also was expected that if participants with PD were able to efficiently use their automatic processes when dopamine was present, the least amount of postural sway would be found when they were on dopamine medications and focusing externally. 18, 19 This was not the case, but rather participants with PD demonstrated significantly greater postural sway when focusing externally while on medications compared with focusing internally while off medications. Lastly, it was expected that postural stability
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would not differ between medication states in participants with PD when an IFA was adopted, as frontal area-mediated control of movement is believed to be less modulated by dopamine compared with automatic control. In contrast to this expectation, participants demonstrated significantly greater postural sway while focusing internally on medications compared with off medications. Although these findings contrast expectations, discussion regarding pathological degeneration in individuals with PD may provide some insight.
Degeneration in the basal ganglia typical of PD has been found to largely implicate functioning of the dorsal striatum 40 -42 that is involved in automatic processes. 10 -12, [43] [44] [45] An EFA may involve the dorsal striatum if it is truly an automatic process (which the current results support). The presence of dopamine replacement (compared with the depletion of dopamine) may exacerbate abnormal transmission exiting the basal ganglia (as opposed to improving basal ganglia output) 46, 47 such that dopamine replacement might force involvement of more degenerated cells than a state in which dopamine is depleted (off dopamine medications). This would potentially explain why adopting an EFA on dopamine impaired postural control compared with an EFA off dopamine. In contrast to the typical progressive degeneration to the dorsal striatum found in individuals with PD, the structural integrity of the ventral striatum involved in goal-directed cognitive processes 48 -51 is typically preserved. 40 -42 Due to dorsal degeneration and ventral preservation, dopaminergic replacement that improves functioning through the dorsal striatum also might overmedicate and impair functioning of the preserved ventral striatum. 52, 53 Therefore, if an IFA, which is believed to be mediated by frontal areas for control of movement, involves cognitive networks comprising the ventral striatum, the presence of dopamine might impair postural control. This supports the study findings, as an IFA on dopamine resulted in significantly worse postural control compared with an IFA off dopamine. In general, focusing internally while off dopamine may have been the only instruction that induced use of neural circuits unaffected by disease progression or imperfect dopamine replacement, thus providing the most optimal control of posture. Impairment of automatic processes naturally shift control of movement from the dorsal striatum to the ventral striatum, 40 thus providing some explanation as to why previous studies also have demonstrated worse postural control while on dopamine compared with off dopamine. 29 -31 Therefore, we also expected that in the control condition, off dopamine postural sway should have proved beneficial to postural control compared with on dopamine postural sway and should have demonstrated similar sway to an IFA condition off dopamine.
Interestingly, the Figure demonstrates that the control condition resulted in the lowest anterior-posterior sway displacement and variability while participants were on dopamine replacement medications (compared with an EFA or IFA) and in the greatest anterior-posterior sway displacement and variability while participants were off dopamine replacement medications. These findings may be the result of comfort level during the difficult experimental protocol. While on dopamine medications, participants with PD may have felt more comfortable without an instruction that forces them to use their dopaminergic system, potentially benefiting performance. In contrast, while off dopamine medications, participants may have felt uncomfortable or anxious, and providing an instruction may have decreased anxiety (via an emotional distraction) associated with the difficult protocol. 54 However, this is speculative, and future work should investigate what strategies were used during the control condition, the participants' comfort level throughout the paradigm, and how anxiety may influence a person's ability to utilize a specific focus of attention instruction, with the use of interviews and questionnaires. Alternatively, the participants may have developed postural control strategies that they use while on their normal dopaminergic medication regimen during day-to-day life that are no longer helpful when off medications, which is not typical of their normal routine.
A final point of observation is that while on dopamine medications, participants with PD did not demonstrate significant improvements in postural control while focusing externally compared with internally, dissimilar to the improvements found by Wulf et al. 18 This finding may have been due to differences in the protocols. Although our study was aimed to replicate the study designed by Wulf et al, 18 utilizing the unstable platform setting on the Biodex Balance System SD would be expected to pose a similar, but not identical, threat to postural control as using an inflated disk placed over a forceplate. Additionally, the present study utilized a longer trial duration compared with the previous study, which may have presented potential for fatigue effects and a greater window for error.
Both of these systematic differences may have increased variability in the data. However, Landers and colleagues 19 found similar results (no statistical difference between focusing externally and focusing internally while on medications), but it was not until those participants with PD categorized as fallers were analyzed separately did they find a significant postural stability improvement with an EFA compared with IFA. The analysis of this study did not categorize participants with a fall history; thus, further research is needed to investigate the interaction among attentional focus, medication state, falls history, and postural control. Future work should additionally investigate neural correlates associated with the interaction between focus of attention and dopamine replacement.
This work provides potential for rehabilitation of not only postural instability in individuals with PD, but also ability to utilize one's automatic systems. If adopting an EFA during movement does promote utilization of automatic processes that are subject to years of degeneration in individuals with PD, attention-based physical therapy rehabilitation (such as goal-based exercise), in which attention is directed externally, may have the efficacy to facilitate improved functioning of these processes, potentially by strength-
ening circuitry through the basal ganglia. [55] [56] [57] [58] [59] This approach would not only improve the individual's ability to control well-learned movements without demand on conscious control, but also potentially improve upon, and slow the progression of, motor symptoms in individuals with PD. Thus, instructing individuals with PD to focus attention externally during exercise may be the missing component that physical therapists require in order to prescribe an exercise program that maximizes benefits for patients with PD. To date, only one innovative investigation has aimed to determine whether an EFA is more beneficial to improve postural instability and gait in individuals with PD. 60 However, after 4 weeks of training (while on dopamine medications), an EFA did not promote significant benefits. Thus, future studies should aim to investigate whether exercise programs of longer duration (12 weeks) that promote diverging attentional focus instruction could drive significant improvements to postural instability in individuals with PD.
Several limitations were present in this study, such as the absence of a healthy age-matched control group. However, as individuals with PD demonstrate improved performance when an EFA is adopted in the presence of dopamine, similar to healthy individuals, participants with PD on medication served as a control. The absence of a healthy agematched control group was additionally beneficial due to reduced problems associated with a between-participants study design. Another limitation is the inherent uncertainty as to whether participants adopted the focus of attention that was instructed. Without a retention or transfer task, this cannot be determined. Furthermore, the present data could not address the interaction between cognitive functioning and attentional focus during postural control in the present paradigm, as the MoCA was administered only while participants were on dopamine medications.
It is logical that a person's ability to adopt a specific mode of attention (ie, external or internal) would depend on, or be influenced by, his or her cognitive functioning. Although, prior to testing, relatable scenarios were described to the participants to ensure that they understood the requirements of each condition, and because there was a wide range of MoCA scores (12-30), these findings may be generalizable to a breadth of cognitive functioning levels among individuals with PD. Nonetheless, it is necessary for future work to investigate the direct influence of cognitive function on the ability to effectively adopt an EFA and IFA during movement. Limiting external validity further was the fact that the task was artificial, which included attempts to control posture on an unstable surface while in a safety harness. As this task would not be undertaken in an individual's everyday routine, and a harness would not be present at the time of a perturbation, natural behavior was undoubtedly influenced. However, the harness precaution was used during both on and off medication assessments, throughout each condition, and with a tension that would not influence postural control, but remain effective if a fall were to have taken place. Regardless, generalizations of these findings to different environments and tasks cannot be made and further work, therefore, is necessary.
Finally, in the event that a fall did occur, data collection for that trial was discontinued and repeated. However, the number of falls was not collected, which may impede generalizability. These falls, as well as task difficulty and testing while off medications, also may have influenced anxiety in participants, a domain that was argued to influence the difference in performance on the control condition compared with the external and internal conditions. However, anxiety was not measured during the protocol and, therefore, presented another limitation to the study.
In general, we found that only when participants were off dopamine replacement, an IFA was more beneficial for control of postural stability in participants with PD compared with both an EFA and a control condition. This finding suggests that an EFA may recruit automatic processes that include degenerated basal ganglia and that lack of dopamine replacement exacerbates dys- 
February 2017 Volume 97 Number 2 Physical Therapy f 7 ening circuitry through the basal ganglia. [55] [56] [57] [58] [59] This approach would not only improve the individual's ability to control well-learned movements without demand on conscious control, but also potentially improve upon, and slow the progression of, motor symptoms in individuals with PD. Thus, instructing individuals with PD to focus attention externally during exercise may be the missing component that physical therapists require in order to prescribe an exercise program that maximizes benefits for patients with PD. To date, only one innovative investigation has aimed to determine whether an EFA is more beneficial to improve postural instability and gait in individuals with PD. 60 However, after 4 weeks of training (while on dopamine medications), an EFA did not promote significant benefits. Thus, future studies should aim to investigate whether exercise programs of longer duration (12 weeks) that promote diverging attentional focus instruction could drive significant improvements to postural instability in individuals with PD.
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